Vol. 66 No. 3 (2022) | European Journal of Histochemistry

Current Issue

Vol. 66 No. 3 (2022)

21 June 2022

View this Issue

Impact Factor 2025

Vol. 66 No. 3 (2022)

Published: 21 June 2022

Articles

Immunofluorescence signal intensity measurements as a semi-quantitative tool to assess sarcoglycan complex expression in muscle biopsy

Simona Zanotti, Francesca Magri, Francesca Poggetti, Michela Ripolone, Daniele Velardo, Francesco Fortunato, Patrizia Ciscato, Maurizio Moggio, Stefania Corti, Giacomo Pietro Comi, Monica Sciacco

https://doi.org/10.4081/ejh.2022.3418

1546

PDF: 941

HTML: 33
- PDF
- HTML
Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication in vitro by reinforcing miR-192-5p/ATG7-induced autophagy

Minkai Cao, Deping Yuan, Hongxiu Jiang, Guanlun Zhou, Chao Chen, Guorong Han

https://doi.org/10.4081/ejh.2022.3438

1613

PDF: 994

HTML: 52
- PDF
- HTML
Inhibition of APLN suppresses cell proliferation and migration and promotes cell apoptosis in esophageal cancer cells in vitro, through activating PI3K/mTOR signaling pathway

Yuhan Wang, Gang Wang, Xiaojun Liu, Dong Yun, Qing Cui, Xiaoting Wu, Wenfeng Lu, Xiwen Yang, Ming Zhang

https://doi.org/10.4081/ejh.2022.3336

1726

PDF: 837

HTML: 51
- PDF
- HTML
MiR-550a-3p restores damaged vascular smooth muscle cells by inhibiting thrombomodulin in an in vitro atherosclerosis model

Shiyuan Chen, Longfei Zhang, Benchi Feng, Wei Wang, Delang Liu, Xinyu Zhao, Chaowen Yu, Xiaogao Wang, Yong Gao

https://doi.org/10.4081/ejh.2022.3429

1333

PDF: 736

Supplementary: 150

HTML: 42
- PDF
- Supplementary
- HTML
Lobetyolin suppressed lung cancer in a mouse model by inhibiting epithelial-mesenchymal transition

Lu Liu, Zhankui Liu, Liu Yang, Xue Wu, Jiaying Zhu, Lili Liu, Yang Liu

https://doi.org/10.4081/ejh.2022.3423

2277

PDF: 964

HTML: 86
- PDF
- HTML
Clinicopathological assessment of cancer/testis antigens NY‑ESO‑1 and MAGE‑A4 in osteosarcoma

Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito, Naohiro Oka, Ryosuke Kakinoki, Masao Akagi

https://doi.org/10.4081/ejh.2022.3377

1873

PDF: 1016

HTML: 29
- PDF
- HTML
Extracellular vesicles from bone mesenchymal stem cells transport microRNA-206 into osteosarcoma cells and target NRSN2 to block the ERK1/2-Bcl-xL signaling pathway

Alimu Keremu, Pazila Aila, Aikebaier Tusun , Maimaitiaili Abulikemu, Xiaoguang Zou

https://doi.org/10.4081/ejh.2022.3394

2144

PDF: 1395

HTML: 32
- PDF
- HTML
Transcription factor nuclear factor erythroid 2 p45-related factor 2 (NRF2) ameliorates sepsis-associated acute kidney injury by maintaining mitochondrial homeostasis and improving the mitochondrial function

Zhijiang Chen, Huili Wang, Bin Hu, Xinxin Chen, Meiyu Zheng, Lili Liang, Juanjuan Lyu, Qiyi Zeng

https://doi.org/10.4081/ejh.2022.3412

2636

PDF: 1494

HTML: 37
- PDF
- HTML
MALAT1 regulates hypertrophy of cardiomyocytes by modulating the miR-181a/HMGB2 pathway

Feng Chen, Wenfeng Li, Dandan Zhang, Youlin Fu, Wenjin Yuan, Gang Luo, Fuwei Liu, Jun Luo

https://doi.org/10.4081/ejh.2022.3426

1550

PDF: 944

HTML: 35
- PDF
- HTML
Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Antonella Vetuschi, Alfredo Cappariello, Paolo Onori, Eugenio Gaudio, Giovanni Latella, Simona Pompili, Roberta Sferra

https://doi.org/10.4081/ejh.2022.3391

4242

PDF: 1997

HTML: 65
- PDF
- HTML
Inhibition of HMGB1 suppresses inflammation and catabolism in temporomandibular joint osteoarthritis via NF-κB signaling pathway

Yan Yan Li, Ya Ping Feng, Li Liu, Jin Ke, Xing Long

https://doi.org/10.4081/ejh.2022.3357

2300

PDF: 1190

HTML: 45
- PDF
- HTML

Remembrances

In memoriam of Prof. GianCarlo Panzica

Editor in Chief

https://doi.org/10.4081/ejh.2022.3527

568

PDF: 408

HTML: 32
- PDF
- HTML

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.